Attention for sex in COVID-19 trials: a review of regulatory dossiers.

de Vries, Sieta T; Starokozhko, Viktoriia; Schellens, Ingrid M M; Wijnans, Leonoor; Enzmann, Harald; Cavaleri, Marco; Mol, Peter G M

de Vries, Sieta T; Starokozhko, Viktoriia; Schellens, Ingrid M M; Wijnans, Leonoor; Enzmann, Harald; Cavaleri, Marco; Mol, Peter G M.

Afiliação

de Vries ST; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Starokozhko V; Dutch Medicines Evaluation Board, Utrecht, The Netherlands.
Schellens IMM; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Wijnans L; Dutch Medicines Evaluation Board, Utrecht, The Netherlands.
Enzmann H; Dutch Medicines Evaluation Board, Utrecht, The Netherlands.
Cavaleri M; Dutch Medicines Evaluation Board, Utrecht, The Netherlands.
Mol PGM; Committee for Medicinal Products for Human Use, European Medicines Agency (EMA), Amsterdam, The Netherlands.

BMJ Glob Health ; 7(3)2022 03.

Article em En | MEDLINE | ID: mdl-35304352

Assuntos

Vacina BNT162; COVID-19; Atenção; Feminino; Humanos; Masculino

Palavras-chave

COVID-19; public health; review; treatment; vaccines

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 / Vacina BNT162 Limite: Female / Humans / Male Idioma: En Revista: BMJ Glob Health Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google